Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene results in increased expression of PLXNB2 mRNA | increases expression | 20406850
|
D016604 |
Aflatoxin B1 |
Aflatoxin B1 affects the expression of PLXNB2 protein | affects expression | 20106945
|
D020122 |
tert-Butylhydroperoxide |
tert-Butylhydroperoxide results in decreased expression of PLXNB2 mRNA | decreases expression | 15336504
|
D004040 |
Dietary Carbohydrates |
Dietary Carbohydrates results in decreased expression of PLXNB2 mRNA | decreases expression | 17490981
|
D010672 |
Phenytoin |
Phenytoin results in decreased expression of PLXNB2 mRNA | decreases expression | 14741686
|
C006253 |
pirinixic acid |
pirinixic acid results in decreased expression of PLXNB2 mRNA | decreases expression | 18445702
|
D012643 |
Selenium |
Selenium results in increased expression of PLXNB2 mRNA | increases expression | 19244175
|
D017632 |
Asbestos, Serpentine |
Asbestos, Serpentine results in increased expression of PLXNB2 mRNA | increases expression | 16251409
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of PLXNB2 mRNA | decreases expression | 15652763
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of PLXNB2 mRNA | increases expression | 17035482
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Phenytoin |
9.64 | 9118846 9677735 6195326 8986270 3425630 10563481 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
9.64 | 15322242 14514962 11752688 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.34 | 18653653 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
10.87 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
10.87 | 16835633 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.14 | 11748828 |
MESH:D001195 |
Asbestosis |
|
Asbestos, Serpentine |
5.91 | 10751356 |
MESH:D050197 |
Atherosclerosis |
|
Phenytoin |
4.04 | 15136057 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
9.46 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
9.46 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
4.11 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.89 | 15746008 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.69 | 20435547 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.96 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
3.11 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
3.11 | 21507988 12907637 12619106 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.47 | 16120746 18670907 18850075 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
2.90 | 6135515 |
MESH:D002493 |
Central Nervous System Diseases |
|
Phenytoin |
5.56 | 4080065 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.34 | 16835633 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
2.97 | 19176532 |
OMIM:601042 |
CHOREOATHETOSIS/SPASTICITY, EPISODIC |
|
Phenytoin |
6.15 | 11748493 |
MESH:D002971 |
Cleft Lip |
|
Phenytoin |
4.25 | 2227380 |
MESH:D002972 |
Cleft Palate |
|
Phenytoin |
6.41 | 3877104 6862529 10789828 2227380 1687470 6856622 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
6.41 | 8697196 16354765 12621046 15668235 15340226 |
MESH:D003092 |
Colitis |
|
Selenium |
4.04 | 17936198 |
MESH:D003103 |
Coloboma |
|
Phenytoin |
5.36 | 9212184 |
MESH:D000013 |
Congenital Abnormalities |
|
Phenytoin |
10.00 | 10627286 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
10.00 | 14669216 17141729 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Phenytoin |
2.89 | 19952982 8986270 9212184 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.89 | 20055451 10048152 15322242 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
4.28 | 18551238 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.51 | 18249437 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.71 | 17107852 |
OMIM:607208 |
DRAVET SYNDROME |
|
Phenytoin |
5.65 | 11748493 |
MESH:D003875 |
Drug Eruptions |
|
Phenytoin |
5.76 | 15024534 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
6.50 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Selenium |
6.50 | 15131321 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
6.50 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.91 | 11462148 |
MESH:D004487 |
Edema |
|
pirinixic acid |
7.23 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
7.23 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.22 | 15322242 16714409 18230668 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Phenytoin |
4.91 | 17654737 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.21 | 10568697 9294722 |
MESH:D004816 |
Epidermal Necrolysis, Toxic |
|
Phenytoin |
5.44 | 20235791 |
MESH:D004820 |
Epidermolysis Bullosa |
|
Phenytoin |
6.55 | 1399206 6251365 |
MESH:D004828 |
Epilepsies, Partial |
|
Phenytoin |
5.23 | 11558140 17116037 |
MESH:D004827 |
Epilepsy |
|
Phenytoin |
4.03 | 821787 11434505 20417680 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Phenytoin |
5.56 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Phenytoin |
5.35 | 3659116 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.16 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
2.97 | 19236843 20131406 |
MESH:D005313 |
Fetal Death |
|
Phenytoin |
11.62 | 10627286 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
11.62 | 11858732 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
3.21 | 20067830 |
MESH:D005885 |
Gingival Hyperplasia |
|
Phenytoin |
5.95 | 9029455 |
MESH:D019214 |
Gingival Overgrowth |
|
Phenytoin |
6.55 | 16390469 14659971 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.91 | 10696789 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.43 | 11294989 10048152 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
7.35 | 20558911 |
MESH:D006333 |
Heart Failure |
|
Selenium |
7.35 | 17162251 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.54 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
9.14 | 16221962 18467677 19772884 19176532 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
9.14 | 15340226 16120746 12621046 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.36 | 8697196 16354765 16959395 15340226 18606429 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.38 | 20558911 |
MESH:D020138 |
Hyperhomocysteinemia |
|
Phenytoin |
4.85 | 10459572 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.97 | 18850075 18670907 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
1.95 | 12200463 12878042 |
MESH:D007251 |
Influenza, Human |
|
Selenium |
4.51 | 16624496 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.76 | 16306350 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.54 | 16580747 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Selenium |
4.09 | 16518626 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
3.15 | 16705839 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
2.19 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
2.19 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Phenytoin |
3.26 | 14986274 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
11.24 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
11.24 | 15890375 18177683 9163691 2125692 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
11.24 | 15890375 20007298 16377806 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
11.24 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
10.51 | 2876784 6135515 2876786 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
10.51 | 8603461 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
10.51 | 12151625 |
MESH:D008171 |
Lung Diseases |
|
Asbestos, Serpentine |
4.48 | 17200189 |
MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
3.67 | 14755239 |
MESH:D008175 |
Lung Neoplasms |
|
Asbestos, Serpentine |
3.67 | 11198217 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
3.67 | 19555203 11884234 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Selenium |
2.88 | 15318939 |
MESH:D008607 |
Mental Retardation |
|
Phenytoin |
3.72 | 9212184 |
MESH:D008654 |
Mesothelioma |
|
Selenium |
2.86 | 15107826 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.76 | 16239165 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.21 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.18 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
3.10 | 16411023 |
MESH:D020191 |
Myoclonic Epilepsies, Progressive |
|
Phenytoin |
5.81 | 17484760 |
MESH:D009224 |
Myotonia Congenita |
|
Phenytoin |
5.69 | 1896199 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
4.15 | 7678174 18551238 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
2.03 | 17405874 |
MESH:D009374 |
Neoplasms, Experimental |
|
Asbestos, Serpentine |
5.10 | 11704859 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.45 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
Phenytoin |
4.25 | 9118846 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.85 | 20558911 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
3.62 | 16049721 |
MESH:D010018 |
Osteomalacia |
|
Phenytoin |
5.69 | 17016548 |
MESH:D010146 |
Pain |
|
Phenytoin |
4.15 | 15215642 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.57 | 12520081 |
MESH:D010954 |
Plasmacytoma |
|
Selenium |
5.21 | 15087411 |
MESH:D010995 |
Pleural Diseases |
|
Asbestos, Serpentine |
5.95 | 10923243 |
MESH:D017689 |
Polydactyly |
|
Phenytoin |
5.23 | 9212184 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.80 | 18163543 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.48 | 11118676 11222880 11896295 11399792 |
MESH:D019310 |
Pseudolymphoma |
|
Phenytoin |
5.86 | 1419762 8603615 12752131 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Asbestos, Serpentine |
3.89 | 15511213 18569384 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.47 | 19058328 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
4.08 | 18990726 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
6.76 | 18551238 |
MESH:D012640 |
Seizures |
|
Phenytoin |
6.76 | 9844417 10029267 19919933 11044598 3691417 15946322 16876388 3137016 |
MESH:D012878 |
Skin Neoplasms |
|
tert-Butylhydroperoxide |
5.88 | 8532709 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
5.88 | 16192470 |
MESH:D013262 |
Stevens-Johnson Syndrome |
|
Phenytoin |
5.41 | 20235791 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.22 | 12697716 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
2.35 | 16049721 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
4.60 | 10091137 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.91 | 12125929 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.57 | 15886252 |